Who owns Transino?
Transino is owned by Daiichi Sankyo Healthcare (Japan).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Daiichi Sankyo Healthcare: History (沿革), Daiichi Sankyo Healthcare Co., Ltd. Last checked .
Key facts
- Current owner
- Daiichi Sankyo Healthcare Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Tokyo
- Origin
- 🇯🇵 Japan
- Founded
- 2007
- Category
- Personal care & beauty › Skin care › Dermocosmetics & clinical skin care
- Last verified
- · 1 sources
About Transino
Brand launched in 2007 with the first Japanese medicine for improving melasma, built on tranexamic acid and developed after requests from clinicians; the company built its own 95-colour scale to evaluate results. A medicated whitening essence followed in 2010, and the skincare series went on sale in Korea in 2012, China in 2019 and Vietnam in 2022.
Ownership timeline of Transino
- Current owner Daiichi Sankyo Healthcare [1] reported
Where Transino sits in Daiichi Sankyo Healthcare
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Daiichi Sankyo Healthcare ownership tree →
See the full Daiichi Sankyo Healthcare brand portfolio (8) →
Other brands owned by Daiichi Sankyo Healthcare
Daiichi Sankyo Healthcare controls 8 brands on Brandtree, 3 of them in personal care & beauty.
Also in personal care & beauty
- Clean Dental (1985)
- Minon (1973)
Other brands in dermocosmetics & clinical skin care, and who owns them
The 41 brands in dermocosmetics & clinical skin care on Brandtree belong to 21 owners. The largest is Ego Pharmaceuticals, with 9; Daiichi Sankyo Healthcare has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| DermAid | Ego Pharmaceuticals | 🇦🇺 Australia |
| Biretix | Cantabria Labs | 🇪🇸 Spain |
| CeraVe | L'Oréal | 🇫🇷 France |
| A-Derma | Pierre Fabre | 🇫🇷 France |
| Dermalogica | Unilever | 🇬🇧 United Kingdom |
| Alastin | Galderma | 🇨🇭 Switzerland |
| A-Solution | Aekyung | 🇰🇷 South Korea |
| Eucerin | Beiersdorf | 🇩🇪 Germany |
Every brand in dermocosmetics & clinical skin care and its owner →
About the owner: Daiichi Sankyo Healthcare
Daiichi Sankyo Healthcare is a privately held company headquartered in Tokyo, Japan, founded in 2005. Brandtree records 8 brands under its control.
Japanese self-care and over-the-counter health company, incorporated on 16 December 2005 and trading from 2006, when the healthcare businesses of Sankyo and Daiichi Seiyaku were combined. Zepharma joined in 2007. Its head office is in Nihonbashi, Tokyo, and it reported sales of 90.7 billion yen for the year to March 2026. Its site is in Japanese only; the brands below come from its launch history and brand list.
Daiichi Sankyo Healthcare: full profile, brands and acquisition history →
🇯🇵 Transino and other Japanese brands
Brandtree records a controlling owner for 437 brands that began in Japan. 21 of them (5%) are now controlled by a company headquartered in another country; Transino is not one of them.
Frequently asked questions
Who is the parent company of Transino?
The parent company of Transino is Daiichi Sankyo Healthcare, a privately held company headquartered in Japan.
Is Transino Japanese?
Yes. Transino originated in Japan in 2007 and its owner, Daiichi Sankyo Healthcare, is also headquartered in Japan.
Is Transino still owned by Daiichi Sankyo Healthcare?
Yes. As of 4 October 2026, Transino is still owned by Daiichi Sankyo Healthcare. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Daiichi Sankyo Healthcare: History (沿革) — Daiichi Sankyo Healthcare Co., Ltd., Official document; retrieved 4 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.